Clinical benefit and safety of boosting the HER2 peptide vaccine (AE37+GM-CSF) in the adjuvant setting to prevent breast cancer recurrence
- Resource Type
- Abstract
- Source
- In
Journal of the American College of Surgeons October 2014 219(4) Supplement:e170-e170 - Subject
- Language
- ISSN
- 1072-7515